Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 38 Specimen Handling 37 Magnetic Resonance Spectroscopy 26 Biopsy 26 Cyclophosphamide 25 Carboplatin 25 fludarabine 21 Nivolumab 20 Gemcitabine 18 Dexamethasone 18 Paclitaxel 15 Rituximab 13 Bevacizumab 13 Pemetrexed 12 Docetaxel 12 atezolizumab 11 Cisplatin 11 Lenalidomide 10 Ipilimumab 10 Fulvestrant 10 venetoclax 9 Prednisone 9 Oxaliplatin 9 olaparib 8 fludarabine phosphate 8 belantamab mafodotin 8 Temozolomide 8 Injections 8 Fluorouracil 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Valacyclovir × 30 days × Clear all

NCT07346144 2026-05-04

ADePT

Trogenix ltd

Phase 1/2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡